110 related articles for article (PubMed ID: 28698141)
21. Pan-cancer methylation and expression profiling of adenocarcinomas revealed epigenetic silencing in the WNT signaling pathway.
Li J; Huang KL; Zhang T; Li H; Zhao J; Wang H
Neoplasma; 2016; 63(2):208-14. PubMed ID: 26774141
[TBL] [Abstract][Full Text] [Related]
22. ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.
Yang J; Han F; Liu W; Chen H; Hao X; Jiang X; Yin L; Huang Y; Cao J; Zhang H; Liu J
J Exp Clin Cancer Res; 2017 Nov; 36(1):170. PubMed ID: 29183346
[TBL] [Abstract][Full Text] [Related]
23. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
24. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
25. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
[TBL] [Abstract][Full Text] [Related]
27. CD151 knockdown inhibits osteosarcoma metastasis through the GSK-3β/β-catenin/MMP9 pathway.
Zhang Z; Wang F; Li Q; Zhang H; Cui Y; Ma C; Zhu J; Gu X; Sun Z
Oncol Rep; 2016 Mar; 35(3):1764-70. PubMed ID: 26707073
[TBL] [Abstract][Full Text] [Related]
28. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic regulation of the pro-apoptosis gene TSSC3 in human osteosarcoma cells.
Li Y; Huang Y; Lv Y; Meng G; Guo QN
Biomed Pharmacother; 2014 Feb; 68(1):45-50. PubMed ID: 24268429
[TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
[TBL] [Abstract][Full Text] [Related]
31. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice.
Kansara M; Tsang M; Kodjabachian L; Sims NA; Trivett MK; Ehrich M; Dobrovic A; Slavin J; Choong PF; Simmons PJ; Dawid IB; Thomas DM
J Clin Invest; 2009 Apr; 119(4):837-51. PubMed ID: 19307728
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
[TBL] [Abstract][Full Text] [Related]
33. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
[TBL] [Abstract][Full Text] [Related]
34. Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/β-catenin signaling pathway.
Liu X; Li L; Lv L; Chen D; Shen L; Xie Z
Oncol Rep; 2015 Aug; 34(2):1035-41. PubMed ID: 26035210
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
36. The Wnt Inhibitor Apcdd1 Coordinates Vascular Remodeling and Barrier Maturation of Retinal Blood Vessels.
Mazzoni J; Smith JR; Shahriar S; Cutforth T; Ceja B; Agalliu D
Neuron; 2017 Dec; 96(5):1055-1069.e6. PubMed ID: 29154126
[TBL] [Abstract][Full Text] [Related]
37. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
38. Apcdd1 stimulates oligodendrocyte differentiation after white matter injury.
Lee HK; Laug D; Zhu W; Patel JM; Ung K; Arenkiel BR; Fancy SP; Mohila C; Deneen B
Glia; 2015 Oct; 63(10):1840-9. PubMed ID: 25946682
[TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
40. The role of APCDD1 in epithelial rearrangement in tooth morphogenesis.
Neupane S; Sohn WJ; Gwon GJ; Kim KR; Lee S; An CH; Suh JY; Shin HI; Yamamoto H; Cho SW; Lee Y; Kim JY
Histochem Cell Biol; 2015 Oct; 144(4):377-87. PubMed ID: 26170146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
